MedTrace Logo

Effects of Embryogen in RIF Patients

NCT02250768 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2014-09-26

No results posted yet for this study

Summary

The purpose of this study was to investigate the potential effects of Granulocyte-Macrophage Stimulating-Colony Factor (GM-CSF) supplementation in embryo culture for patients with repeated implantation failure (RIF)

Conditions

Interventions

BIOLOGICAL

GM-CSF

2ng/ml of GM-CSF supplemented into culture media

Sponsors & Collaborators

  • Vietnam National University

    lead OTHER

Principal Investigators

  • Vinh Q Dang, Dr · Research Center for Genetics and Reproductive Health

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-03-31
Completion
2014-08-31

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02250768 on ClinicalTrials.gov